Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation

被引:32
|
作者
Broglie, Martina A. [1 ]
Soltermann, Alex [2 ]
Rohrbach, David [2 ]
Haile, Sarah R. [3 ]
Pawlita, Michael [4 ]
Studer, Gabriela [5 ]
Huber, Gerard F. [6 ]
Moch, Holger [2 ]
Stoeckli, Sandro J. [1 ]
机构
[1] Kantonsspital St Gallen, Dept Otorhinolaryngol Head & Neck Surg, CH-9007 St Gallen, Switzerland
[2] Univ Zurich Hosp, Inst Surg Pathol, Zurich, Switzerland
[3] Kantonsspital St Gallen, Clin Trials Unit, CH-9007 St Gallen, Switzerland
[4] German Canc Res Ctr, Res Program Infect & Canc, Dept Genome Modificat & Carcinogenesis, Heidelberg, Germany
[5] Univ Zurich Hosp, Dept Radiat Oncol, Zurich, Switzerland
[6] Univ Zurich Hosp, Dept Otorhinolaryngol Head & Neck Surg, Zurich, Switzerland
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2013年 / 35卷 / 12期
关键词
oropharyngeal squamous cell carcinoma; outcome; survival; HPV; p16; smoking; alcohol; p53; intensity modulated radiotherapy; risk stratification; GROWTH-FACTOR RECEPTOR; HUMAN-PAPILLOMAVIRUS; NECK-CANCER; RADIATION-THERAPY; TONSILLAR CARCINOMAS; HEAD; RADIOTHERAPY; EXPRESSION; PROGNOSIS; RISK;
D O I
10.1002/hed.23231
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
BackgroundAnalysis of the impact of risk factors on survival in patients with oropharyngeal squamous cell carcinoma (OPSCC) treated by primary intensity-modulated radiotherapy (IMRT). MethodsOne hundred forty patients were included with tissue microarray (TMA) construction and immunohistochemical analysis in 124 patients (87%). ResultsSurvival analysis of patients classified into 3 risk categories according to an algorithm based on p16, smoking, T classification, and N classification revealed significant differences with a low, intermediate, and high-risk group. There was a significant impact of p53 expression as surrogate marker for smoking on outcome. In multivariate analysis, p16-positivity was a positive predictor and alcohol as well as N classification was a negative predictor for survival. The algorithm was modified based on alcohol instead of smoking with even more significant differences between the groups. ConclusionsA risk model based on multiple factors instead of p16 as single marker can define different risk groups to select patients for treatment deintensification in future prospective clinical trials. (c) 2013 Wiley Periodicals, Inc. Head Neck 35: 1698-1706, 2013
引用
收藏
页码:1698 / 1706
页数:9
相关论文
共 50 条
  • [1] Intensity-Modulated Radiotherapy Outcomes for Oropharyngeal Squamous Cell Carcinoma Patients Stratified by p16 Status
    Shoushtari, Asal
    Meeneghan, Mathew
    Sheng, Ke
    Moskaluk, Christopher A.
    Thomas, Christopher Y.
    Reibel, James F.
    Levine, Paul A.
    Jameson, Mark J.
    Keene, Kimberly
    Read, Paul W.
    CANCER, 2010, 116 (11) : 2645 - 2654
  • [2] Prognostic Impact of p16 and p53 Expression in Oropharyngeal Squamous Cell Carcinomas
    Shinohara, Shogo
    Kikuchi, Masahiro
    Tona, Risa
    Kanazawa, Yuji
    Kishimoto, Ippei
    Harada, Hiroyuki
    Imai, Yukihiro
    Usami, Yu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (03) : 232 - 240
  • [3] Oropharyngeal squamous cell carcinoma: p16/p53 immunohistochemistry as a strong predictor of HPV tumour status
    Benzerdjeb, Nazim
    Tantot, Juliet
    Blanchet, Christophe
    Philouze, Pierre
    Mekki, Yahia
    Lopez, Jonathan
    Devouassoux-Shisheboran, Mojgan
    HISTOPATHOLOGY, 2021, 79 (03) : 381 - 390
  • [4] Prognostic significance of p16, p53, Bcl-2, and Bax in oral and oropharyngeal squamous cell carcinoma
    Thongsuksai, Paramee
    Pruegsanusak, Kowit
    Boonyaphiphat, Pleumjit
    ASIAN BIOMEDICINE, 2014, 8 (02) : 255 - 261
  • [5] The Prognostic Significance of the Biomarker p16 in Oropharyngeal Squamous Cell Carcinoma
    Oguejiofor, K. K.
    Hall, J. S.
    Mani, N.
    Douglas, C.
    Slevin, N. J.
    Homer, J.
    Hall, G.
    West, C. M. L.
    CLINICAL ONCOLOGY, 2013, 25 (11) : 630 - 638
  • [6] The Clinical Relevance of p16 and p53 Status in Patients with Squamous Cell Carcinoma of the Vulva
    Barlow, Ellen L.
    Lambie, Neil
    Donoghoe, Mark W.
    Naing, Zin
    Hacker, Neville F.
    JOURNAL OF ONCOLOGY, 2020, 2020
  • [7] Prognostic value of p16 expression and alcohol consumption in Japanese patients with oropharyngeal squamous cell carcinoma
    Saito, Yuki
    Yoshida, Masafumi
    Ushiku, Tetsuo
    Omura, Go
    Ebihara, Yasuhiro
    Shimono, Toshiyuki
    Fukayama, Masashi
    Yamasoba, Tatsuya
    Asakage, Takahiro
    CANCER, 2013, 119 (11) : 2005 - 2011
  • [8] Intensity-modulated radiation therapy as primary treatment for oropharyngeal squamous cell carcinoma
    May, James T.
    Rao, Nikhil
    Sabater, Roberto D.
    Boutrid, Hinda
    Caudell, Jimmy J.
    Merchant, Faisal
    Han, Gang
    Padhya, Tapan A.
    McCaffrey, Judith C.
    Tanvetyanon, Tawee
    Deconti, Ronald
    Kish, Julie
    McCaffrey, Thomas V.
    Trotti, Andy
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2013, 35 (12): : 1796 - 1800
  • [9] Prognostic Significance of p16 Cellular Localization in Oropharyngeal Squamous Cell Carcinoma
    Lai, Syeling
    Wenaas, Ashley E.
    Sandulache, Vlad C.
    Hartman, Christine
    Chiao, Elizabeth
    Kramer, Jennifer
    Zevallos, Jose P.
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2016, 46 (02) : 132 - 139
  • [10] Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality?
    Fischer, Claude A.
    Zlobec, Inti
    Green, Edith
    Probst, Simone
    Storck, Claudio
    Lugli, Alessandro
    Tornillo, Luigi
    Wolfensberger, Markus
    Terracciano, Luigi M.
    INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (05) : 1256 - 1262